91 Results

People

  1. Motzer
    Motzer
  2. Makker
    Makker
  3. Abou-Alfa
    Abou-Alfa
  4. Drilon
    Drilon
  5. Lee
    Lee
  6. Voss
    Voss
  7. Wong
    Wong
  8. Aghajanian
    Aghajanian
  9. Carlo
    Carlo
  10. Konner
    Konner

Groups

  1. Department of Medicine (72)
  2. Solid Tumor Oncology Division (70)
  3. Genitourinary Oncology Service (30)
  4. GDMT, Medicine (18)
  5. Gynecologic Medicine Service (18)
  6. Gynecology Disease Management Team (18)
  7. Radiology, Department of (12)
  8. Gastrointestinal Oncology Service (11)
  9. Center for Pancreatic Cancer Research (9)
  10. Weinberg Fellows (9)
  1. "lenvatinib"
Formats
  1. Journal Article (58)
  2. Review (19)
  3. Editorial (3)
  4. Guidelines (3)
  5. Research Letter (3)
  6. Correspondence (2)
  7. Meeting Abstract (2)
  8. Book Section (1)
Groups
  1. Department of Medicine (72)
  2. Solid Tumor Oncology Division (70)
  3. Genitourinary Oncology Service (30)
  4. GDMT, Medicine (18)
  5. Gynecologic Medicine Service (18)
  6. Gynecology Disease Management Team (18)

More Groups

People
  1. Robert Motzer (25)
  2. Vicky Makker (16)
  3. Ghassan Abou-Alfa (9)
  4. Chung-Han Lee (7)
  5. Alexander Drilon (4)
  6. Martin Voss (4)

More People

Years
  1. 2025 (9)
  2. 2024 (18)
  3. 2023 (18)
  4. 2022 (12)
  5. 2021 (11)
  6. 2020 (9)

More Years

Publications
  1. European Urology (5)
  2. Cancers (4)
  3. The Oncologist (4)
  4. Annals of Oncology (3)
  5. Journal of Clinical Oncology (3)
  6. Journal of Gastrointestinal Oncology (3)

More Publications

Publishers
  1. Elsevier Inc. (16)
  2. Elsevier Science, Inc. (8)
  3. Oxford University Press (8)
  4. MDPI (4)
  5. Nature Publishing Group (4)
  6. Wiley Blackwell (4)

More Publishers

Results (91)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
    Guidelines

    Oaknin, A.; Bosse, T. J.; Creutzberg, C. L.; Giornelli, G.; Harter, P.; Joly, F.; Lorusso, D.; Marth, C.; Makker, V.; Mirza, M. R.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Up to seven criteria in selection of systemic therapy for hepatocellular carcinoma
    Review

    Silk, T.; Silk, M.; Wu, J.
    World Journal of Gastroenterology (2022)

    Fulltext@MSK | Save
  • Central retinal vein occlusion in the setting of fibroblast growth factor receptor inhibition
    Journal Article

    Foulsham, W.; Edghill, B. Z.; Canestraro, O. D. J.; Makker, V.; Konner, J.; Abramson, D. H.; Francis, J. H.
    American Journal of Ophthalmology Case Reports (2022)

    Fulltext@MSK | Save
  • Health-related quality-of-life outcomes in patients with advanced renal cell carcinoma treated with lenvatinib plus pembrolizumab or everolimus versus sunitinib (CLEAR): A randomised, phase 3 study
    Journal Article

    Motzer, R.; Porta, C.; Alekseev, B.; Rha, S. Y.; Choueiri, T. K.; Mendez-Vidal, M. J.; Hong, S. H.; Kapoor, A.; Goh, J. C.; Eto, M.; more...
    Lancet Oncology (2022)

    Fulltext@MSK | Save
  • Lenvatinib dose, efficacy, and safety in the treatment of multiple malignancies
    Review

    Motzer, R. J.; Taylor, M. H.; Evans, T. R. J.; Okusaka, T.; Glen, H.; Lubiniecki, G. M.; Dutcus, C.; Smith, A. D.; Okpara, C. E.; Hussein, Z.; more...
    Expert Review of Anticancer Therapy (2022)

    Fulltext@MSK | Save
  • Lenvatinib plus pembrolizumab for advanced endometrial cancer
    Journal Article

    Makker, V.; Colombo, N.; Casado Herráez, A.; Santin, A. D.; Colomba, E.; Miller, D. S.; Fujiwara, K.; Pignata, S.; Baron-Hay, S.; Ray-Coquard, I.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • Emerging evidence for VEGF and immune checkpoint inhibition in oesophagogastric cancer
    Correspondence

    Ilson, D. H.
    The Lancet Gastroenterology & Hepatology (2022)

    Fulltext@MSK | Save
  • Characterization and management of adverse reactions in patients with advanced endometrial carcinoma treated with lenvatinib plus pembrolizumab
    Journal Article

    Makker, V.; Taylor, M. H.; Oaknin, A.; Casado Herraez, A.; Orlowski, R.; Dutta, L.; Ren, M.; Zale, M.; O'Malley, D. M.
    The Oncologist (2021)

    Fulltext@MSK | Save
  • Treatment of advanced gastroenteropancreatic neuroendocrine neoplasia, are we on the way to personalised medicine?
    Review

    Rinke, A.; Auernhammer, C. J.; Bodei, L.; Kidd, M.; Krug, S.; Lawlor, R.; Marinoni, I.; Perren, A.; Scarpa, A.; Sorbye, H.; more...
    Gut (2021)

    Fulltext@MSK | Save
  • Lenvatinib plus pembrolizumab for renal cell carcinoma - The authors reply
    Correspondence

    Motzer, R.; Choueiri, T. K.
    New England Journal of Medicine (2021)

    Fulltext@MSK | Save